150 related articles for article (PubMed ID: 4781249)
1. Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance.
Cohn JN
Circulation; 1973 Jul; 48(1):5-8. PubMed ID: 4781249
[No Abstract] [Full Text] [Related]
2. Blood pressure and cardiac performance.
Cohn JN
Am J Med; 1973 Sep; 55(3):351-61. PubMed ID: 4746558
[No Abstract] [Full Text] [Related]
3. Reduction of myocardial ischemic injury and left ventricular dysfunction by vasodilator therapy.
Carraway RD
South Med J; 1979 Nov; 72(11):1436-44. PubMed ID: 388650
[No Abstract] [Full Text] [Related]
4. [Vasodilator therapy of congestive heart failure].
Schröder R
Dtsch Med Wochenschr; 1977 Sep; 102(39):1388-94. PubMed ID: 410617
[No Abstract] [Full Text] [Related]
5. Outflow resistance as a regulator of left ventricular performance.
Franciosa JA
Angiology; 1978 May; 29(5):393-401. PubMed ID: 655470
[No Abstract] [Full Text] [Related]
6. Vasodilator therapy for chronic heart failure.
Mason DT; Awan NA; Demaria AN; Lee G; Joye JA; Amsterdam EA
Compr Ther; 1979 Jul; 5(7):6-14. PubMed ID: 383392
[No Abstract] [Full Text] [Related]
7. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B
G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186
[No Abstract] [Full Text] [Related]
8. Peripheral vasodilators in the treatment of cardiac failure.
Forrester JS; da Luz PL
Adv Cardiol; 1976; 17():123-32. PubMed ID: 818884
[No Abstract] [Full Text] [Related]
9. Vasodilator therapy for left ventricular failure.
Jacobs WR; Loeb HS; Gunnar RM
Geriatrics; 1981 Apr; 36(4):137-43. PubMed ID: 7203016
[No Abstract] [Full Text] [Related]
10. [Effect of benefit of preload reduction in coronary heart disease].
Simon H
Med Klin (Munich); 1987 Jan; 1():6-9. PubMed ID: 3472031
[No Abstract] [Full Text] [Related]
11. [Treatment of cardiac insufficiency with vasodilators].
Salazar Dávila E
Cardiology; 1980; 66 Suppl 2():146-53. PubMed ID: 7285025
[No Abstract] [Full Text] [Related]
12. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator treatment for acute and chronic heart failure.
Warren SE; Dennish G
Br Heart J; 1978 Sep; 40(9):1059-60. PubMed ID: 708533
[No Abstract] [Full Text] [Related]
14. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
[TBL] [Abstract][Full Text] [Related]
15. [Vasodilator therapy in cardiac insufficiency].
Vincent JL; Goldstein J; Leeman M; Lignian H
Rev Med Brux; 1984 Nov; 5(9):589-92. PubMed ID: 6522891
[No Abstract] [Full Text] [Related]
16. Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure.
Fraccarollo D; Galuppo P; Neuser J; Bauersachs J; Widder JD
Hypertension; 2015 Nov; 66(5):978-87. PubMed ID: 26351025
[TBL] [Abstract][Full Text] [Related]
17. [Chronic use of vasodilators in congestive cardiac insufficiency].
Quesada Vargas O
Cardiology; 1980; 66 Suppl 2():169-76. PubMed ID: 7285027
[No Abstract] [Full Text] [Related]
18. Editorial: Reducing the work load of the failing heart.
Vaisrub S
JAMA; 1973 Dec; 226(11):1350-1. PubMed ID: 4800763
[No Abstract] [Full Text] [Related]
19. Vasodilators have not been shown to be of value in all patients with chronic congestive heart failure due to left ventricular systolic dysfunction.
Kulick DL; Rahimtoola SH
Am J Cardiol; 1990 Aug; 66(4):435-8. PubMed ID: 2201177
[No Abstract] [Full Text] [Related]
20. [Clinical trial of the new coronary dilator hexobendine].
Henke C; Dudik E; Steim H
Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
[No Abstract] [Full Text] [Related]
[Next] [New Search]
